1. Home
  2. WNC vs PEPG Comparison

WNC vs PEPG Comparison

Compare WNC & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WNC

Wabash National Corporation

HOLD

Current Price

$9.07

Market Cap

307.1M

Sector

Industrials

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.24

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNC
PEPG
Founded
1985
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.1M
317.6M
IPO Year
1991
2022

Fundamental Metrics

Financial Performance
Metric
WNC
PEPG
Price
$9.07
$5.24
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$9.00
$9.50
AVG Volume (30 Days)
509.2K
831.0K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
3.53%
N/A
EPS Growth
N/A
N/A
EPS
6.15
N/A
Revenue
$1,638,115,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.72
N/A
P/E Ratio
$1.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.78
$0.88
52 Week High
$20.63
$6.85

Technical Indicators

Market Signals
Indicator
WNC
PEPG
Relative Strength Index (RSI) 63.99 51.14
Support Level $8.40 $5.04
Resistance Level $9.02 $6.72
Average True Range (ATR) 0.33 0.58
MACD 0.19 -0.04
Stochastic Oscillator 89.77 28.54

Price Performance

Historical Comparison
WNC
PEPG

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Share on Social Networks: